This post was originally published on this site
https://i-invdn-com.investing.com/trkd-images/LYNXMPEI9J0ES_L.jpg
The deal, announced last month, was expected to face a tough antitrust review even though the two companies do not compete directly in any market, according to experts.
The acquisition will enable CVS, one of the largest U.S. healthcare companies, to provide further care management to patients in their homes.
The deal is still expected to close in the first half of 2023, CVS said in a filing.
